2m 2m 2m 2m 2m 2m 2m
KYVERNA THERAP (KYTX)
NASDAQ
$7.28+$0.02 (+0.22%)
Price as of Sep 11, 2026 7:30 PM EDT- $449.0MMarket Cap
- 85.20%1-Year Change
- BiotechnologyIndustry
KYVERNA THERAP (KYTX)
$7.28+$0.02 (+0.22%)
KYTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.26 | ||
Change | -$0.09 (-1.22%) | ||
Open | $7.47 | ||
High | $7.59 | ||
Low | $7.21 | ||
Previous Close | $7.35 | ||
Volume | 751,625 | ||
30-Day Average Volume | 752,339 | ||
1-Week Change | -12.00% | ||
1-Month Change | -9.48% | ||
1-Year Change | 85.20% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 61.8M | ||
Total Assets | $219.8M | ||
Market Cap | $449.0M | ||
Enterprise Value | $442.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$38.3M | ||
Free Cash Flow | -$40.3M | ||
EBIT | -$37.6M | ||
EBITDA | -$37.2M | ||
Net Working Capital | $183.7M | ||
EPS | -$0.63 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -12 | ||
PEG | -3 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue